Friday, November 22, 2024
HomeTagsSolid Tumors

Solid Tumors

Innovent and Laekna Jointly Announce First Patient Dosed with Three-drug Combination

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and other...

Medicare Extends Coverage of Natera’s Signatera MRD Test to Muscle Invasive Bladder Cancer

Natera, Inc., a global leader in cell-free DNA testing, announced that it has received written confirmation from the CMS Molecular Diagnostics Services Program (MolDX)...

Antengene Announces IND Approval in China for the Phase I Study of ATG-101 for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma

Antengene Corporation Limited, a leading innovative commercial stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and...

Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors

Ascletis Pharma Inc.  announces the approval of the Investigational New Drug (IND) application by U.S. Food and Drug Administration (FDA) for in-house developed oral...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics